IRIS
FERRARINI, MANLIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.100
AS - Asia 395
SA - Sud America 87
NA - Nord America 47
AF - Africa 10
Totale 13.639
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 13.089
SG - Singapore 173
CN - Cina 104
VN - Vietnam 85
BR - Brasile 55
US - Stati Uniti d'America 33
AR - Argentina 16
HK - Hong Kong 13
MX - Messico 11
ZA - Sudafrica 6
IQ - Iraq 5
CL - Cile 4
ID - Indonesia 4
EC - Ecuador 3
EG - Egitto 3
UA - Ucraina 3
UY - Uruguay 3
PK - Pakistan 2
PY - Paraguay 2
VE - Venezuela 2
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CO - Colombia 1
CR - Costa Rica 1
GA - Gabon 1
GB - Regno Unito 1
GE - Georgia 1
IE - Irlanda 1
IN - India 1
JM - Giamaica 1
JO - Giordania 1
LB - Libano 1
MT - Malta 1
PA - Panama 1
PL - Polonia 1
PS - Palestinian Territory 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
Totale 13.639
Salva come PNG Salva come JPEG
Città #
Genova 8.373
Genoa 2.807
Rapallo 1.141
Vado Ligure 748
Singapore 80
Ho Chi Minh City 31
Beijing 23
Ashburn 21
Hanoi 18
Bordighera 17
Hong Kong 12
Mexico City 9
Biên Hòa 5
Phủ Lý 5
Haiphong 4
Brasília 3
Cairo 3
Da Nang 3
Johannesburg 3
São Paulo 3
Baghdad 2
Belford Roxo 2
Cedral 2
Changsha 2
Dalian 2
Durban 2
Guangzhou 2
Hangzhou 2
Los Angeles 2
Montevideo 2
New York 2
Quito 2
Quảng Ngãi 2
San Miguel de Tucumán 2
Thái Nguyên 2
Tianjin 2
Alta Floresta 1
Alto Paraíso de Goiás 1
Amman 1
Aparecida de Goiânia 1
Avaré 1
Bahía Blanca 1
Baku 1
Bandar Seri Begawan 1
Barcelona 1
Beirut 1
Boston 1
Brotas de Macaúbas 1
Brusaporto 1
Buenos Aires 1
Bugojno 1
Bình Dương 1
Bắc Giang 1
Bắc Ninh 1
Bến Cầu 1
Caaporã 1
Campanha 1
Can Tho 1
Candeias 1
Cape Town 1
Caruaru 1
Caxias do Sul 1
Cerro Navia 1
Chengdu 1
Ciudad del Este 1
Cixi 1
Cochabamba 1
Cosmópolis 1
Cuiabá 1
Curitiba 1
Córdoba 1
Denver 1
Dhaka 1
Divinópolis 1
Donetsk 1
Duhok 1
Dungarvan 1
Eunápolis 1
Formosa 1
Goiás 1
González Catán 1
Gramado 1
Granjeiro 1
Guayaquil 1
Hortolândia 1
Indaiatuba 1
Ituzaingó 1
Juiz de Fora 1
Khmelnytskyi 1
Kyiv 1
Laranjal Paulista 1
Las Breñas 1
Las Heras 1
Libreville 1
Linares 1
Lomas de Zamora 1
Maceió 1
Mairiporã 1
Mauá 1
Medan 1
Totale 13.405
Salva come PNG Salva come JPEG
Nome #
B CELL CHRONIC LYMPHOCYTIC LEUKEMIA: Lessons Learned from Studies of the B Cell Antigen Receptor. 201
Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens. 196
B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. 180
Biological and clinical relevance of quantitative global methylation of repetitive DNA sequences in chronic lymphocytic leukemia. 179
More on the determination of Ki-67 as a novel potential prognostic marker in B-cell chronic lymphocytic leukemia. 176
Chronic lymphocytic leukemia: a proliferation of B cells at two distinct stages of differentiation 167
Igs expressed by chronic lymphocytic leukemia B cells show limited binding-site structure variability. 163
Apoptosis of Burkitt's lymphoma cells induced by specific interaction of surface IgM with a self-antigen: implications for lymphomagenesis in acquired immunodeficiency syndrome. 162
APOPTOSIS OR PLASMA CELL DIFFERENTIATION OF CD38-POSITIVE B-CHRONIC LYMPHOCYTIC LEUKEMIA CELLS INDUCED BY CROSS-LINKING OF SURFACE IGM OR IGD 161
BAFF serum level predicts time to first treatment in early chronic lymphocytic leukemia. 157
A non-invasive approach to monitor chronic lymphocytic leukemia engraftment in a xenograft mouse model using ultra-small superparamagnetic iron oxide-magnetic resonance imaging (USPIO-MRI) 155
B lymphocytes in humans express ZAP-70 when activated in vivo. 154
Microenvironmental regulation of the IL-23R/IL-23 axis overrides chronic lymphocytic leukemia indolence 153
Accumulation of clonally-related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients 151
A prognostic model based on combining estrogen receptor expression and Ki-67 value after neoadjuvant chemotherapy predicts clinical outcome in locally advanced breast cancer: extension and analysis of a previously reported cohort of patients. 148
Prognostic relevance of serum levels and cellular expression of adiponectin in B-cell chronic lymphocytic leukemia. 147
Serum level of CD26 predicts time to first treatment in early B-chronic lymphocytic leukemia. 146
Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. 145
B-cell chronic lymphocytic leukaemia/small lymphocytic lymphoma: role of ZAP-70 determination on bone marrow biopsies 143
The CD38 ectoenzyme family: advances in basic science and clinical practice 142
Analysis of the stepwise genetic changes that occurred in an AIDS-related Burkitt\'s lymphoma. 140
Clonal heterogeneity in chronic lymphocytic leukemia cells: superior response to surface IgM cross-linking in CD38, ZAP-70-positive cells. 139
The human marginal zone B cell 136
Relevance of HBV/HBcAb screening in lymphoma patients treated in the Rituximab era 136
Analysis of stepwise genetic changes in an AIDS-related Burkitt's lymphoma. 135
Patients Treated with Rituximab-Containing Immunochemotherapy Have a Significant and Prolonged Lack of Humoral Response to Influenza Vaccine Associated with a Persistent Depletion of B Memory Cells 134
CD26 expression in mature B-cell neoplasia: its possible role as a new prognostic marker in B-CLL. 134
An Increased Number of Individuals with Clinically Recognized Monoclonal B-Cell Lymphocytosis Characterizes a Recent Database of Chronic Lymphocytic Leukemia Rai Stage 0. 133
Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities. 131
Low percentage of KRAS mutations revealed by locked nucleic acid polymerase chain reaction: implications for treatment of metastatic colorectal cancer. 130
Characterizing Features of Human Circulating B Cells Carrying CLL-Like Stereotyped Immunoglobulin Rearrangements 129
A phase II trial with Cisplatin-Paclitaxel cytotoxic treatment and concurrent external and endocavitary radiation therapy in locally advanced or recurrent cervical cancer. 129
Evidence for progenitors of chronic lymphocytic leukemia B cells that undergo intraclonal differentiation and diversification. 128
CD38 and chronic lymphocytic leukemia: a decade later. 128
Recent advances in the molecular biology and immunobiology of chronic lymphocytic leukemia. 127
Chromosome aberrations evaluated by comparative genomic hybridization in B cell chronic lymphocytic leukemia: correlation with CD38 expression 127
SUBEPITHELIAL B CELLS IN THE HUMAN PALATINE TONSIL. II. FUNCTIONAL CHARACTERIZATION 127
Similarities and differences between the light and heavy chain Ig variable region gene repertoires in chronic lymphocytic leukaemia. 126
Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia 126
In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells 126
Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: implication for therapy 126
PNAEμ can significantly reduce Burkitt’s Lymphoma tumor burden in a SCID mice model: cells dissemination similar to the human disease 126
Optimization of a wga-free molecular tagging-based ngs protocol for ctcs mutational profiling 126
Apoptotic cells overexpress vinculin and induce vinculin-specific cytotoxic T cell cross-priming, depending on their capacity to activate dendritic cells. 125
Immunoglobulin V region gene use and structure suggest antigen selection in AIDS-related primary effusion lymphomas 125
Chronic lymphocytic leukaemia 124
Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia. 124
CD 10 is a marker for cycling cells with propensity to apoptosis in childhood ALL 124
Apoptosis of Burkitt\'s lymphoma cells induced by specific interaction of surface IgM with a self-antigen. Implications for lymphomagenesis in AIDS. 124
Mutation pattern of paired immunoglobulin heavy and light variable domains in chronic lymphocytic leukemia B-cells 123
Chromosome 2p gain in monoclonal B-cell lymphocytosis and in early stage chronic lymphocytic leukemia. 123
Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia 122
Increased serum BAFF (B-cell activating factor of the TNF family) level is a peculiar feature associated with familial chronic lymphocytic leukemia. 122
Effects in live cells of a c-myc anti-gene PNA linked to a nuclear localization signal. 121
Chronic lymphocytic leukemia B cells can undergo somatic hypermutation and intraclonal immunoglobulin V(H)DJ(H) gene diversification. 121
Immunoglobulin Gene Mutation Patterns and Heterogeneity of Marginal Zone Lymphoma 121
Definition of progression risk based on combinations of cellular and molecular markers in patients with Binet stage A chronic lymphocytic leukaemia. 121
CASE 1. Complete remission to corticosteroids in an octreotide-refractory thymoma 119
Expression of CD10 by human T cells that undergo apoptosis both in vitro and in vivo. 118
Transfection of the c-myc oncogene into normal Epstein-Barr virus-harboring B cells results in new phenotypic and functional features resembling those of Burkitt lymphoma cells and normal centroblasts. 118
Evolving view of the in-vivo kinetics of chronic lymphocytic leukemia B cells. 118
Recent views on B cell chronic lymphocytic leukemia pathophysiology 116
Serum thrombopoietin compared with ZAP-70 and immunoglobulin heavy-chain gene mutation status as a predictor of time to first treatment in early chronic lymphocytic leukemia. 116
Maintenance of B lymphocyte-related clones in the cerebrospinal fluid of multiple sclerosis patients. 115
Role of surface IgM and IgD on survival of the cells from B-cell chronic lymphocytic leukemia. 114
Impaired Humoral Response to Influenza Vaccine and Prolonged B Memory Cell Depletion as a Consequence of Rituximab-based Immunochemotherapy in non-Hodgkin Lymphoma Patients 114
Late Epstein-Barr virus infection of a hepatosplenic gamma delta T-cell lymphoma arising in a kidney transplant recipient. 114
Therapeutically promising PNA complementary to a regulatory sequence for c-myc: pharmacokinetics in an animal model of human Burkitt's lymphoma 114
IMMUNOGLOBULIN V GENE MUTAITON STATUS AND CD38 EXPRESSION AS NOVEL PROGNOSTIC INDICATORS IN CHRONIC LYMPHOCYTIC LEUKEMIA 113
Second-line treatment with intravenous gemcitabine and oral etoposide in platinum-resistant advanced ovarian cancer patients: results of a phase II study. 113
Identification of three subgroups of B-CELL chronic lymphocytic leukemia based upon mutations of BCL-6 and Ig V genes 112
Clinical and laboratory parameters that define clinically relevant B-CLL subgroups. 112
Immunoglobulin V genes and CD38 expression analysis in B cell chronic lymphocytic leukemia. Blood. Letter 109
The cumulative amount of serum-free light chain is a strong prognosticator in chronic lymphocytic leukemia. 108
The propensity to apoptosis of centrocytes and centroblasts correlates with elevated levels of intracellular myc protein. 107
Tracing CLL-biased stereotyped immunoglobulin gene rearrangements in normal B cell subsets using a high-throughput immunogenetic approach 104
The opposite effects of IL-15 and IL-21 on CLL B cells correlate with differential activation of the JAK/STAT and ERK1/2 pathways 103
Interleukin-21 receptor (IL-21R) is up-regulated by CD40 triggering and mediates pro-apoptotic signals in chronic lymphocytic leukemia B cells 103
Integrative genomics analyses reveal molecularly distinct subgroups of B-cell chronic lymphocytic leukemia patients with 13q14 deletion. 103
Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of chronic lymphocytic leukemia. 103
Immunoglobulin heavy chain variable region gene and prediction of time to first treatment in patients with chronic lymphocytic leukemia: Mutational load or mutational status? Analysis of 1003 cases 102
Inhibition of Burkitt's lymphoma cells growth in SCID mice by a PNA specific for a regulatory sequence of the translocated c-myc 101
Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patients 101
Markers of increased angiogenesis and their correlation with biological parameters identifying high-risk patients in early B-cell chronic lymphocytic leukemia 100
CD5(+) B cells with the features of subepithelial B cells found in human tonsils 99
Heterogeneous expression and function ofIL-21R and susceptibility to IL-21-mediated apoptosis in follicular lymphoma cells. 99
Serum-associated inhibition of neutrophil Fc receptors in cancer patients. 99
Frequent mutation of the 5’ noncoding region of the BCL-6 gene in acquired immunodeficiency syndrome-related non-Hodgkin’s lymphomas 98
Clinical categories identified by a new prognostic index reflect biological characteristics of patients in earlychronic lymphocytic leukemia: The Gruppo Italiano Studio Linfomi (GISL)experience. 98
Chronic lymphocytic leukemia 97
TRANSFECTION OF THE C-MYC ONCOGENE INTO NORMAL EBV-HARBORING B CELLS RESULTS IN NEW PHENOTYPIC AND FUNCTIONAL FEATURES RESEMBLING THOSE OF BURKITT LYMPHOMA CELLS AND NORMAL CENTROBLASTS 96
Lack of mutagenicity and clastogenicity of PNAEmu-NLS targeted to a regulatory sequence of the translocated c-myc oncogene in Burkitt's lymphoma 96
CD38 EXPRESSION DISTINGUISHES TWO GROUPS OF B CELL-CHRONIC LYMPHOCYTIC LEUKEMIAS WITH DIFFERENT RESPONSE TO ANTI IgM ANTIBODIES AND PROPENSITY TO APOPTOSIS 94
Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro. Haematologica 93
Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization to detect chromosomal abnormalities in chronic lymphocytic leukemia: a comparative study. 93
The peptide nucleic acid targeted to a regulatory sequence of the translocated c-myc oncogene in Burkitt's lymphoma lacks immunogenicity: follow-up characterization of PNAEmu-NLS 92
Intraclonal cell expansion and selection driven by B cell receptor in chronic lymphocytic leukemia 90
Examples of in vivo isotype switching in IgM+ chronic lymphocytic leukemia B cells 84
Telomere lenght and telomerase activity delineate distinctive replicative features of the B/CLL subgroups defined by immunoglobulin V gene mutations 83
The patterns of IL2, IFN-gamma, IL4 and IL5 gene expression in Hodgkin's disease and reactive lymph nodes are similar. 82
Totale 12.408
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.400
article - articoli 41.672
book - libri 0
conference - conferenze 361
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 367
Totale 84.800
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021442 0 0 0 0 0 58 47 74 71 89 47 56
2021/20221.239 46 75 91 141 42 69 80 305 53 132 34 171
2022/20231.375 140 91 11 173 228 271 6 124 249 6 65 11
2023/2024663 24 97 13 62 72 135 36 38 28 19 49 90
2024/20251.898 51 157 51 129 227 196 165 269 60 93 229 271
2025/20261.368 368 79 151 290 408 72 0 0 0 0 0 0
Totale 13.741